Robert B. Laprairie

Statistics

Publications

Citations

4.2K

H-Index

Active since

2012

Affiliations

Dalhousie University(Current)

University of Saskatchewan

Northeastern University

University of Aberdeen

Yukon University

Robert B. Laprairie is an author at Dalhousie University specializing in cannabinoid pharmacology, pharmacology, and cannabinoid receptor pharmacology.

ORCID

Publications per year

2012–2025

Publications

Cannabidiol is a negative allosteric modulator of the cannabinoid CB <sub>1</sub> receptor

Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly et al. · British Journal of Pharmacology · 2015 · 1K citations · Full text

Life Sciences, Neuroscience, Pharmacology +13

Crystal Structure of the Human Cannabinoid Receptor CB1

Tian Hua, Kiran Vemuri, Mengchen Pu et al. · Cell · 2016 · 678 citations · Full text

Natural Sciences, Biochemistry, Pharmacology +14

RETRACTED ARTICLE: Crystal structures of agonist-bound human cannabinoid receptor CB1

Tian Hua, Kiran Vemuri, Spyros P. Nikas et al. · Nature · 2017 · 505 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili et al. · British Journal of Pharmacology · 2018 · 315 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa

Ayat Zagzoog, Kawthar A. Mohamed, Hye Ji J. Kim et al. · Scientific Reports · 2020 · 172 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–5 of 52